Bloomington’s 2025 economic story is about adapting and rising to meet challenges. Flexibility, strategic investment and ...

COPENHAGEN (Reuters) -Novo Nordisk's top executives ignored internal warnings that the company was not sufficiently prepared ...

Hims & Hers Health continues to eye personalized services and global expansion. Read more on what investors should know about ...

Novo Nordisk has terminated its partnership with telehealth company Hims & Hers Health, accusing it of deceptively marketing weight-loss drugs.

The companies engaged in an increasingly heated war of words on Monday following the drugmaker's decision to end a ...

Novo Nordisk cut off Hims & Hers Health from selling lower-priced Wegovy on Monday morning, but its explanation for the ...

Novo Nordisk on Friday said full results from early-stage trials show that its experimental drug, amycretin, helped overweight and obese adults lose up to 24% of their weight as the Danish company ...

The Connect Transit board has approved the sale of a vacant lot for a planned shelter village in Bloomington. The shelter village, called The Bridge, is intended to be a low-barrier, non-congregate ...

The Bloomington-Normal community will mark Juneteenth on Saturday during an event at Miller Park, featuring live music and dance, activities for kids, and a ceremony commemorating three community ...

Novo Nordisk sees the obesity drug market expanding to $100 billion by 2030. With promising new treatments in the pipeline, 24/7 Wall St. projects huge upside through the end of the decade.

Novo Nordisk has taken initiatives to accelerate target discovery by implementing AI/ML technologies into genetic and human-centric in vitro models. Given the significant costs associated with drug ...